Latest Canada News

Strata Investment Holdings delivered a £16.48 million comprehensive profit for H1 2026, driven by a strong revaluation of its investment portfolio and maiden royalty income from Botswana copper assets.

Neuren Pharmaceuticals reported an 8% rise in H1 2026 revenues driven by DAYBUE royalties, but profit fell 68% due to ramped-up R&D. The company declared its first ever dividend, signalling confidence amid ongoing clinical and regulatory milestones.

Manhattan Gold Corporation’s latest drilling at the Jaws target within the Hook Lake Project delivers multiple broad gold intercepts with improved grades and thickness over historic data, extending mineralisation over 150 metres southwest and confirming significant upside potential.

The Koala Company posted a $24.6 million profit for FY26 on $332.3 million revenue, surpassing IPO forecasts with strong international growth and margin gains.

Biome Australia has delivered a standout FY26 with sales up 30% to $23.9 million and net profit after tax soaring to $3.6 million, bolstered by a non-cash deferred tax asset. The company strengthened its balance sheet while expanding manufacturing and international distribution.

Paladin Energy Ltd (ASX:PDN) reversed prior losses with a net profit of US$5.3 million in FY2026, driven by a strong ramp-up of uranium production at Namibia's Langer Heinrich Mine and regulatory progress at its Canadian Patterson Lake South Project.

Terragen Holdings posted a slight increase in net loss to AUD 3.75 million for FY2026, while advancing key commercial trials and securing a $7 million equity raise to fuel growth.

Neuren Pharmaceuticals’ partner Acadia Pharmaceuticals secured European Commission approval for DAYBU (trofinetide) to treat Rett syndrome symptoms in patients aged five and older, marking the first EU-authorised treatment for this condition.

Aurelia Metals has appointed Steve Badenhorst as its new Managing Director and CEO, effective 6 October 2026, aiming to leverage his 35 years of global mining experience to drive operational performance and strategic growth.

Tourism Holdings Limited (thl) posted a $39.9 million statutory net profit after tax for FY26, reversing a prior year loss, while navigating geopolitical headwinds and receiving competing takeover bids.

Cyclopharm Limited posted a fifth consecutive record half-year revenue of $17.5 million, propelled by a 74% jump in US Technegas® sales and a doubling of revenue-generating US sites. New US clinical guidelines naming Technegas® as the preferred ventilation imaging agent underpin a robust growth outlook despite a wider net loss.

Powerhaus Uranium launches an IPO to raise up to A$10 million, aiming to accelerate uranium exploration in underexplored Argentine provinces and acquire a Canadian Athabasca Basin project. The company’s flagship Malbec Project shows promising early-stage results, with plans for extensive drilling and in-situ recovery methods.